| scholarly article | Q13442814 |
| P50 | author | Henning Reis | Q41451626 |
| Herbert Rübben | Q107851709 | ||
| P2093 | author name string | Florian Grabellus | |
| Kurt Werner Schmid | |||
| Tibor Szarvas | |||
| Stephan Tschirdewahn | |||
| P2860 | cites work | Cancer statistics, 2010 | Q27860525 |
| Vitamin C crosses the blood-brain barrier in the oxidized form through the glucose transporters | Q28379253 | ||
| Biology of urothelial tumorigenesis: insights from genetically engineered mice | Q33554361 | ||
| Glucose transporters are abundant in cells with "occluding" junctions at the blood-eye barriers | Q33613755 | ||
| Staging and reporting of urothelial carcinoma of the urinary bladder | Q34984796 | ||
| Molecular and cellular regulation of glucose transporter (GLUT) proteins in cancer. | Q35897181 | ||
| Glucose transporter-1 expression in urothelial papilloma of the bladder | Q36090096 | ||
| 18F-FDG PET/CT of transitional cell carcinoma | Q37637510 | ||
| GLUT1 and CAIX as intrinsic markers of hypoxia in bladder cancer: relationship with vascularity and proliferation as predictors of outcome of ARCON. | Q38602274 | ||
| The glucose transporter family: structure, function and tissue-specific expression. | Q40780047 | ||
| Expression of glucose transporters in head-and-neck tumors. | Q42505365 | ||
| Correlation between glucose transporter-1 expression and 18F-fluoro-2-deoxyglucose uptake on positron emission tomography in lung cancer | Q42939978 | ||
| Glut 1 expression in transitional cell carcinoma of the urinary bladder is associated with poor patient survival. | Q43573136 | ||
| Immunohistochemical expression and prognostic significance of FAS and GLUT1 in bladder carcinoma. | Q44393426 | ||
| The relationship between the glucose transporter type 1 expression and F-fluorodeoxyglucose uptake in esophageal squamous cell carcinoma | Q46100041 | ||
| Investigation of pericytes, hypoxia, and vascularity in bladder tumors: association with clinical outcomes. | Q46453780 | ||
| Over-expression of facilitative glucose transporter genes in human cancer | Q48932689 | ||
| Wide expression of the human erythrocyte glucose transporter Glut1 in human cancers. | Q53815780 | ||
| Immunohistochemical localization of glucose transporters in human renal cell carcinoma | Q72558607 | ||
| Overexpression of Glut-1 glucose transporter in human breast cancer. An immunohistochemical study | Q72559241 | ||
| Expression of the human erythrocyte glucose transporter in transitional cell carcinoma of the bladder | Q73503651 | ||
| [Expression of hypoxia inducible factor-1alpha and glucose transporter protein 1 in renal and bladder cancers and the clinical significance thereof] | Q79300164 | ||
| [Update on urothelial carcinoma histopathology] | Q81692044 | ||
| Bladder cancer | Q84058686 | ||
| P433 | issue | 6 | |
| P304 | page(s) | 1149-1153 | |
| P577 | publication date | 2011-08-29 | |
| P1433 | published in | Oncology Letters | Q20640514 |
| P1476 | title | Expression of GLUT1 is associated with increasing grade of malignancy in non-invasive and invasive urothelial carcinomas of the bladder | |
| P478 | volume | 2 |
| Q53186470 | An analysis of the polymorphisms of the GLUT1 gene in urothelial cell carcinomas of the bladder and its correlation with p53, Ki67 and GLUT1 expressions. |
| Q92740760 | Competitive glucose metabolism as a target to boost bladder cancer immunotherapy |
| Q42370634 | Expression of glucose transporter-1 is correlated with hypoxia-inducible factor 1α and malignant potential in pancreatic neuroendocrine tumors |
| Q61799673 | High Glucose with Insulin Induces Cell Cycle Progression and Activation of Oncogenic Signaling of Bladder Epithelial Cells Cotreated with Metformin and Pioglitazone |
| Q92618871 | Immunhistochemical expression of GLUT1 is associated with low grade and low stage of urinary bladder cancer |
| Q38883031 | The progression from a lower to a higher invasive stage of bladder cancer is associated with severe alterations in glucose and pyruvate metabolism |
| Q30440958 | Urothelial signaling |
| Q52897587 | Utility of early dynamic and delayed post-diuretic 18F-FDG PET/CT SUVmax in predicting tumour grade and T-stage of urinary bladder carcinoma: results from a prospective single centre study. |
Search more.